Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/16107
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Williamson, Timothy J | - |
dc.contributor.author | Pearson, John R | - |
dc.contributor.author | Ischia, Joseph J | - |
dc.contributor.author | Bolton, Damien M | - |
dc.contributor.author | Lawrentschuk, Nathan | - |
dc.date | 2016-01-08 | - |
dc.date.accessioned | 2016-08-03T06:13:11Z | - |
dc.date.available | 2016-08-03T06:13:11Z | - |
dc.date.issued | 2016-04 | - |
dc.identifier.citation | BJU International 2016; 117(4): 555-562 | en_US |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/16107 | - |
dc.description.abstract | The purpose of this article was to review and compare the international guidelines and surveillance protocols for post-nephrectomy renal cell carcinoma (RCC). PubMed database searches were conducted, according to the PRISMA statement for reporting systematic reviews, to identify current international surveillance guidelines and surveillance protocols for surgically treated and clinically localized RCC. A total of 17 articles were reviewed. These included three articles on urological guidelines, three on oncological guidelines and 11 on proposed strategies. Guidelines and strategies varied significantly in relation to follow-up, specifically with regard to the frequency and timing of radiological imaging. Although there is currently no consensus within the literature regarding surveillance protocols, various guidelines and strategies have been developed using both patient and tumour characteristics. | en_US |
dc.subject | Guideline | en_US |
dc.subject | Kidney neoplasms | en_US |
dc.subject | Nephronectomy | en_US |
dc.subject | Outcomes | en_US |
dc.subject | Recurrence | en_US |
dc.title | Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | BJU International | en_US |
dc.identifier.affiliation | Austin Health, Heidelberg, Victoria, Australia | en_US |
dc.identifier.affiliation | Surgery (University of Melbourne) | en_US |
dc.identifier.affiliation | Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia | en_US |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en_US |
dc.identifier.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/26617405 | en_US |
dc.identifier.doi | 10.1111/bju.13384 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0002-5145-6783 | en_US |
dc.identifier.orcid | 0000-0001-8553-5618 | en_US |
dc.type.austin | Journal Article | en_US |
local.name.researcher | Bolton, Damien M | |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Neurosurgery | - |
crisitem.author.dept | Urology | - |
crisitem.author.dept | Urology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.